editor.mrrjournal@gmail.com +91-9650568176 E-ISSN: 2584-184X
Submit Paper

MRR

  • Home
  • About Us
    • INDEXING
    • JOURNAL POLIICY
    • PLAGIARISM POLICY
    • PEER REVIEW POLICY
    • OPEN ACCESS POLICY
    • PUBLICATION ETHICS
    • PRIVACY STATEMENT
  • Editorial Board
  • Publication Info
    • Article Submission
    • Submission Guidelines
    • Publication Ethics
    • Journal Policies
    • Aim and Scope
  • Articles & Issues
    • Current Issue
    • Archives
  • Authors Instruction
  • Contact

MRR Journal

Indian Journal of Modern Research and Reviews, 2024; 2(8):28-39

Renal Damage a Worldwide Trouble with Its Risk Factors and Amelioration

Authors: Samina Yesmin; Tasneem Rahman Shamma; Trisha Paul;

1. Scientific Officer, Biomedical and Toxicological Research Institute, BCSIR, Dhaka, Bangladesh

2. University of Rajshahi, Rajshahi, Bangladesh

3. Scientific Officer, Biomedical and Toxicological Research Institute, BCSIR, Dhaka, Bangladesh

Paper Type: Research Paper
Article Information
Received: 2024-06-09   |   Accepted: 2024-07-28   |   Published: 2024-08-26
Abstract

Acute kidney injury (AKI), formerly called acute renal failure (ARF), is commonly defined as decline and damage of renal function, with a reversible acute increase in nitrogen waste products—measured by blood urea nitrogen (BUN) and serum creatinine levels over hours to weeks. It’s generally characterized by the risk, injury, failure, loss, and end-stage kidney disease (RIFLE). In last decay, reducing or protecting against its nephrotoxicity has become the most concerning one. This article reviews some of the literature published during the last decade on the effects of agents that ameliorate or augment GM nephrotoxicity. Notable among the ameliorating agents are antioxidant agents. During the last decade, ameliorating nephrotoxicity has gained much effort and attention throughout the world. Most of the ameliorating agents are antioxidant agents, hormones (melatonin), β-blockers (metoprolol), vitamins (Vit. C and E), Superoxide dismutase, Iron chelators (fereptossin), and some medicinal plants (garlic). Other ameliorating agents include antibiotics (e.g. ceftriaxone), antiplatelet drugs (e.g. trapidil), and Ca++. Some agents that may augment nephrotoxicity include cyclosporin and the Ca++-channel blocker (verapamil), antibiotics (Gentamicin), chemotherapeutics (Doxorubicin), PPIs, and NSAIDs. Although these augmenting agents are vital agents for life threatening conditions, so we have to find out the ameliorating agents which may reduce and protect against nephrotoxicity. Various drugs (i.e., cobicistat, trimethoprim, and cimetidine) are potent inhibitors of these transporters, affecting the tubular secretion component of Cr clearance and can increase SCr levels by 0.2–0.4 mg/dL and decrease Cr clearance by 15–34 mL/min. Some antibiotics (piperacillin, tazobactam, and vancomycin) could significantly diminish the number and activity of organic anion transporters (OAT) on the basolateral membranes of proximal tubular cells and cause impaired Cr secretion and increased SCr, with apparent AKI. The risk factors that are included in AKI are prolonged duration of therapy, concomitant nephron-toxin exposure, and a variety of comorbidities.

Abbreviations: AKI (Acute kidney injury), OAT (Organic anion transporter), SCr (Serum Creatinine)

Keywords

Reciprocal, Peer Tutoring, Academic Strategy, Achievement, Interest Business Studies and Gender

How to Cite

. Renal Damage a Worldwide Trouble with Its Risk Factors and Amelioration. Indian Journal of Modern Research and Reviews. 2024; 2(8):28-39

Download PDF

Useful Links

  • Home
  • About us
  • Editorial Board
  • Current Issue
  • All Issues
  • Submit Paper

Indexing

MRR

Contact Us

Phone: +91-9650568176
Email: editor.mrrjournal@gmail.com | editor.mrrjournal@gmail.com

© Copyright MRR 2023. All Rights Reserved